Sandacanol (Sandranol) is a selective agonist of olfactory receptor OR10H1. Research indicates it can inhibit bladder cancer cell proliferation and migration by inducing cell cycle arrest and partial apoptosis, making it a useful tool for studying olfactory receptor signaling in cancer biology.